CCA
ASTX

Catalyst Capital Advisors’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Catalyst Capital Advisors’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-20,000
Closed -$170K – 366
2013
Q3 		$170K Buy
+20,000
New +$127K 0.09% 227

Catalyst Capital Advisors's ASTX Position: Q4 2013 in Review

Catalyst Capital Advisors sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 20,000 shares — an estimated $170K sold.

Catalyst Capital Advisors first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $170K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Catalyst Capital Advisors reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Catalyst Capital Advisors sold 20,000 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $170K.
  • Catalyst Capital Advisors first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
  • Catalyst Capital Advisors's ASTEX PHARMACEUTICALS, INC COM position peaked at $170K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Catalyst Capital Advisors's 13F filing for Q4 2013, filed 13 Feb 2014.